Director, New Products Planning, Global Marketing

Your Role: The Director, New Product Planning (NPP) will drive Commercial strategies for early assets to ensure the development of innovative, differentiated products that meet unmet needs in Immuno-Oncology.
The rapid development of the EMDS pipeline may yield robust data in Phase I/II in high, unmet-need patient populations which will inform late stage development; thus, there is an urgency for strong and robust Commercial input to maximize the potential of the oncology portfolio. Accordingly, the core responsibilities associated with Director role are to (1) ensure Commercial leadership for early assets, (2) ensure strategic and tactical involvement in pipeline development decisions and program support and (3) strengthen and expand the NPP partnership with Business Development (BD).
Ensure Leadership for Early Asset Strategies
In collaboration with R&D, lead and drive the development of clear, aligned strategies consistent with the Immuno-Oncology GBF (Global Business Franchise) Strategy for all early-to-later stage assets in preparation for go/no-go decisions by Senior Leadership and provide for every decision-making committee meeting a Commercial Assessment and/or Commercial Viewpoint Summary to help guide Senior Leadership decisions
Lead initiatives to continually assess the commercial values, competitive landscapes and market differentiations (incorporating KOL advice) of the early assets and develop and communicate Commercial's priorities for resource allocation and decision making
Pro-actively identify potential BD opportunities, challenges, access issues, LCM options and risks in order to maximize the value of the early asset portfolio
Drive the partnerships and processes with key stakeholders to define, develop, execute and communicate business-critical early asset strategic initiatives as identified by the Immuno-Oncology GBF
In collaboration with cross-functional Oncology teams develop early asset strategies and ensure alignment on visions, objectives and strategies across Brand and Pipeline programs
Build strong relationships and collaborations with R&D, Medical Affairs, Portfolio Management, Clinical, Regulatory, Finance and other key functions and teams
Ensure Strategic and Tactical Involvement in Early Asset Development Decisions and Program Support
Establish the early asset team as a partner with R&D and Clinical in designing pre-clinical and clinical studies and trials and in making differentiation-impacting decisions including determining clinical hurdles, go/no go criteria, endpoints, clinically meaningful comparators, labeling and launch timings
Develop strategic and tactical templates/playbooks that describes progression of activities including, early positioning, segmentation, competitive landscapes, patient journeys, KOL mapping, INNs and brand naming
Drive Commercial input for portfolio reviews and Commercial Assessments
Ensure that up-to-date, aligned and approved TPVPs (Target Product Value Profiles) and Commercial Assessments are uploaded and maintained on the Portfolio Management Platform
Develop and maintain early asset dashboards for monthly communications to Senior Leadership on visions, strategies, opportunities, challenges, risks and tactical activities for the early asset programs
Strengthen and Expand the Partnership with BD (Business Development)
Become a strong partner with BD to provide timely and robust Commercial input and analyses to BD opportunities including Commercial Assessments, due diligence support, business cases and commercial recommendations
Provide leadership in identifying, assessing and prioritizing opportunities identified by the BD Team consistent with Immuno-Oncology GBF strategy and facilitate rapid decisions to go no/go to due diligence and/or deal negotiations
Who You Are:
Degrees / advanced degree(s) in life sciences required; MBA preferred but not required
Relevant pharmaceutical marketing experience; oncology experience a plus
Leadership Experience
10+ years of professional experience
Previous global launch and/or regional launch experience preferred
Outstanding relationship-building and partnering skills and the ability to lead multidisciplinary teams to drive commercial input on development programs
As a key strategic link between scientists and business leaders, must have a strong understanding of drug development as well as highly effective analytical, extrapolative thinking and influencing skills
Able to work effectively in a highly complex matrix environment, with a proven ability to influence without formal authority and achieve results through people
Deep understanding of pharmaceutical business and development space
Strong understanding of the future direction of oncology with respect to diagnostic development with biomarkers and market access trends worldwide
Normal and routine office duties
Position requires domestic and international travel up to 20% of time
Job Requisition ID: 181887
Location: Rockland
Career Level: D - Professional (4-9 years)
Working time model: full-time

Don't Be Fooled

The fraudster will send a check to the victim who has accepted a job. The check can be for multiple reasons such as signing bonus, supplies, etc. The victim will be instructed to deposit the check and use the money for any of these reasons and then instructed to send the remaining funds to the fraudster. The check will bounce and the victim is left responsible.